Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Colleague Insights
Grand Rounds
Conferences
Video Expert Opinion
Living Resources
Sign in
Join now
Ileana Piña MD, MPH, FAHA, FACC
Ileana L. Piña MD, MPH, FAHA, FACC Advisory Board
Paul Thompson MD
Paul D. Thompson MD Advisory Board
Deepak Bhatt MD, MPH, FACC, FAHA, FESC, MSCAI
Deepak L. Bhatt MD, MPH, FACC, FAHA, FESC, MSCAI Advisory Board
See All Experts
featured
Published in Cardiology and
3 other channels

Journal Scan / Research · March 22, 2023

Patient Characteristics, Outcomes, and Effects of Dapagliflozin According to the Duration of Heart Failure

Circulation

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Ileana Piña MD, MPH, FAHA, FACC

Circulation
Patient Characteristics, Outcomes, and Effects of Dapagliflozin According to the Duration of Heart Failure: A Prespecified Analysis of the DELIVER Trial
Circulation 2023 Mar 06;[EPub Ahead of Print], T Kondo, KS Jering, CJW Borleffs, RA de Boer, BL Claggett, AS Desai, D Dobreanu, SE Inzucchi, AF Hernandez, SP Janssens, P Jhund, MN Kosiborod, CSP Lam, AM Langkilde, FA Martinez, M Petersson, PN Vinh, M Vaduganathan, SD Solomon, JJV McMurray

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated